In vivo, in vitro, in silico:
Why computer modelling is the next evolution of the healthcare sector

 

04th September 2018, 15:00-17:00

Room PHS 5B001, European Parliament, Brussels

 

 

15.00 – 15:10

Introduction by Chairs

Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)

15:10 – 15:40

In silico medicine and the Avicenna Alliance: Making Medicine Modern

Thierry Marchal, Secretary General, Avicenna Alliance

Michael Hill, VP Science, Technology and Clinical Affairs, Medtronic

Geena Malhotra, Global Head of Integrated Product Development, Cipla

15:40 – 15:50

V&V40 EU – Verification and Validation in CM&S of Medical Devices

Tina M. Morrison, Deputy Director, Division of Applied Mechanics and Chair of Modeling and Simulation Working Group, FDA

15:50 – 16:15

Feedback and questions from Participants

Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance

16:15 – 16:25

CM&S and medicinal products’ lifecycle

Dr. Ingrid Klingmann, European Forum for Good Clinical Practice

16:25 – 16:50

Feedback and questions from Participants

Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance

16:50 – 17:00

Closing remarks and next steps by Co-Chairs

Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)

17:00 – 18:00

Networking reception and Q&A with speakers

Avicenna Alliance news

EU and China cooperation dialogue for STI

On 9 April, the fourth Innovation Cooperation Dialogue, co-chaired by the European Commissioner for Research, Science and Innovation, Carlos Moedas and the...

find out more ›

Stryker joins the Avicenna Alliance

The Avicenna Alliance is proud to announce the newest addition to its list of members: Stryker. Stryker is one of the world’s leading medical technology companies...

find out more ›

FEops HEARTguideTM receives CE mark

The Avicenna Alliance Secretariat is proud to announce that one of its members, FEops, has received the ‘CE’ mark for its FEops HEARTguideTM.

The CE marking...

find out more ›

Show all activites